SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹1,051 Cr | ₹134,033 Cr | ₹1,320 Cr | ₹1,010 Cr | ₹834 Cr |
What is the latest Revenue of SUVEN PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2025 | ₹1,051 Cr |
Mar2024 | ₹134,033 Cr |
Mar2023 | ₹1,320 Cr |
Mar2022 | ₹1,010 Cr |
Mar2021 | ₹834 Cr |
How is Revenue of SUVEN PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹1,051 Cr | -99.22 | |
Mar2024 | ₹134,033 Cr | 10,052.30 | |
Mar2023 | ₹1,320 Cr | 30.75 | |
Mar2022 | ₹1,010 Cr | 21.10 | |
Mar2021 | ₹834 Cr | - |
Compare Revenue of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹34,795.6 Cr | -7.6% | 1.7% | -20.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -7.6% |
1.7% |
-20.9% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses